Outcomes of transcatheter aortic valve replacement in end stage liver and renal disease

Outcomes of transcatheter aortic valve replacement in end stage liver and renal disease

Objectives This study evaluates in‐hospital, 30‐day, and 1‐year outcomes post‐transcatheter aortic valve replacement (TAVR) in end stage liver disease (ESLD) and/or end stage renal disease (ESRD) compared with patients without these comorbidities. Background TAVR is an alternative to surgical aortic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Catheterization and cardiovascular interventions 2021-07, Vol.98 (1), p.159-167
Hauptverfasser: Caughron, Hope, Parikh, Devang, Allison, Zev, Deuse, Tobias, Mahadevan, Vaikom S.
Format: Artikel
Sprache:eng
Schlagworte:
Aged
Aged, 80 and over
Aortic valve
Aortic Valve - diagnostic imaging
Aortic Valve - surgery
Aortic Valve Stenosis - diagnostic imaging
Aortic Valve Stenosis - surgery
Cardiac & Cardiovascular Systems
Cardiovascular System & Cardiology
Heart transplantation
Humans
Kidney diseases
Kidney transplantation
Life Sciences & Biomedicine
Liver
Liver diseases
liver failure
Liver transplantation
Liver transplants
Middle Aged
Mortality
organ failure
Patients
renal failure
Risk Factors
Science & Technology
Time Factors
Transcatheter Aortic Valve Replacement - adverse effects
transplant
Treatment Outcome
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives This study evaluates in‐hospital, 30‐day, and 1‐year outcomes post‐transcatheter aortic valve replacement (TAVR) in end stage liver disease (ESLD) and/or end stage renal disease (ESRD) compared with patients without these comorbidities. Background TAVR is an alternative to surgical aortic valve replacement in patients with ESLD and ESRD, though current outcomes data are limited. Methods We compared 309 patients (N = 29 ESLD and/or ESRD, N = 280 control) age > 18 who underwent transfemoral TAVR from 2014 to 2020 have been compared. Results Patients with ESLD and ESRD were younger (69.9 ± 11.7 vs. 79.1 ± 9.8, p 
ISSN:1522-1946
1522-726X
DOI:10.1002/ccd.29559